Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The COP-BLAM therapy for malignant lymphoma].

N Arai1, A Hara, M Umeda

  • 1First Department of Internal Medicine, Toho University School of Medicine, Tokyo.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|July 1, 1990
PubMed
Summary

COP-BLAM therapy achieved a 100% effective ratio in treating malignant lymphoma patients. This chemotherapy regimen showed significant efficacy, even in recurrent cases, with manageable side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Properties and tissue distribution of mouse monomeric carbonyl reductase.

Biological & pharmaceutical bulletin·1998
Same author

Transport of fragmented DNA in apical dendrites of gerbil CA1 pyramidal neurons following transient forebrain ischemia.

Brain research·1998
Same author

Enhancement of peroxynitrite-evoked acetylcholine release by hydroxyl radical scavengers from mouse cerebral cortical neurons.

Life sciences·1998
Same author

Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA.

The Biochemical journal·1998
Same author

Protective effect of apoptosis-inhibitory agent, N-tosyl-L-phenylalanyl chloromethyl ketone against ischemia-induced hippocampal neuronal damage.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·1998
Same author

Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.

Japanese journal of cancer research : Gann·1998

Area of Science:

  • Oncology
  • Hematology
  • Clinical Pharmacology

Context:

  • Malignant lymphoma treatment landscape.
  • Emerging therapies for hematologic malignancies.
  • Evaluation of chemotherapy regimens.

Purpose:

  • To assess the efficacy and safety of COP-BLAM therapy in malignant lymphoma.
  • To analyze treatment outcomes based on disease stage and recurrence.
  • To document adverse effects associated with COP-BLAM therapy.

Summary:

  • COP-BLAM therapy demonstrated a 100% overall effective ratio (32 complete remissions, 4 partial remissions) in 36 malignant lymphoma patients.
  • Complete remission rates were high across all stages (100% in Stages I/II, 84% in Stages III/IV).
  • The therapy showed promise in recurrent cases (50% CR) and exhibited mild adverse effects, including leukocytopenia, thrombocytopenia, gastrointestinal symptoms, neuropathy, and alopecia.

Related Experiment Videos

Impact:

  • COP-BLAM therapy offers a highly effective treatment option for malignant lymphoma.
  • The regimen's efficacy extends to recurrent disease, providing a valuable alternative.
  • Manageable adverse effects contribute to its favorable clinical profile.